JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
VOL. 72, NO. 5, 2018
ª 2018 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION PUBLISHED BY ELSEVIER
THE PRESENT AND FUTURE COUNCIL PERSPECTIVES
A Clinician’s Guide for Trending Cardiovascular Nutrition Controversies Part II Andrew M. Freeman, MD,a Pamela B. Morris, MD,b Karen Aspry, MD,c Neil F. Gordon, MD, PHD,d Neal D. Barnard, MD,e Caldwell B. Esselstyn, MD,f Emilio Ros, MD, PHD,g,h Stephen Devries, MD,i,j James O’Keefe, MD,k Michael Miller, MD,l Dean Ornish, MD,m,n Kim A. Williams, MD,o Travis Batts, MD,p Robert J. Ostfeld, MD, MSC,q Sheldon Litwin, MD,r Monica Aggarwal, MD,s Andrea Werner, MSW,t Kathleen Allen, BA,u Beth White, DNP, RN, NP-C, AACC,v Penny Kris-Etherton, PHD, RDw
ABSTRACT The potential cardiovascular (CV) benefits of many trending foods and dietary patterns are still incompletely understood, and scientific inquiry continues to evolve. In the meantime, however, a number of controversial dietary patterns, foods, and nutrients have received significant media attention and are mired by “hype.” This second review addresses some of the more recent popular foods and dietary patterns that are recommended for CV health to provide clinicians with current information for patient discussions in the clinical setting. Specifically, this paper delves into dairy products, added sugars, legumes, coffee, tea, alcoholic beverages, energy drinks, mushrooms, fermented foods, seaweed, plant and marinederived omega-3-fatty acids, and vitamin B12. (J Am Coll Cardiol 2018;72:553–68) © 2018 by the American College of Cardiology Foundation.
The views expressed in this paper by the American College of Cardiology’s (ACC’s) Prevention of Cardiovascular Disease Council do not necessarily reflect the views of the Journal of the American College of Cardiology or the ACC. From the aDivision of Cardiology, Department of Medicine, National Jewish Health, Denver, Colorado; bDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina; cDivision of Cardiology, Department of Medicine, Lifespan Cardiovascular Institute and Brown University, Providence, Rhode Island; Savannah, Georgia;
e
d
INTERVENT International,
George Washington University School of Medicine, Physicians Committee for Responsible Medicine,
Washington, DC; fCleveland Clinic Wellness Institute, Cleveland, Ohio; gLipid Clinic, Endocrinology and Nutrition Service, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Barcelona, Spain; hCiber Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain; iGaples Institute for Integrative Cardiology, Deerfield, Illinois; jDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; kDepartment of Cardiology, Saint Luke’s Mid America Heart Institute, Kansas City, Missouri; lDivision of Cardiology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland; n
m
Preventive Medicine Research Institute, Sausalito, California;
Department of Medicine, University of California, San Francisco, San Francisco, California; oDivision of Cardiology, Department
of Medicine, Rush University Medical Center, Chicago, Illinois; pDivision of Cardiology, Department of Medicine, Wilford Hall Ambulatory Surgical Center, San Antonio, Texas; qDivision of Cardiology, Department of Medicine, Montefiore Health System, Bronx, New York; rDivision of Cardiology, Department of Medicine, Ralph H. Johnson Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, South Carolina; sDivision of Cardiology, Department of Medicine, University of Florida, Gainesville, Florida; tDepartment of Cardiovascular & Pulmonary Medicine, Bellin Health, Green Bay, Wisconsin; uDepartment of Food and Nutrition, New York-Presbyterian, New York, New York; vDepartment of Cardiology, Marshall University Joan C. Listen to this manuscript’s audio summary by JACC Editor-in-Chief Dr. Valentin Fuster.
Edwards School of Medicine, Huntington, West Virginia; and the
w
Department of Nutritional Sciences, Penn State University,
University Park, Pennsylvania. CIBEROBN is an initiative of ISCIII, Spain. Dr. Freeman has done nonpromotional speaking for Boehringer Ingelheim. Dr. Morris has served on advisory boards for Amgen and Sanofi Regeneron. Dr. Aspry has been involved with contracted research for Amgen and Akcea-Ionis; and has received honoraria from the National Lipid Association and MedScape. Dr. Gordon is a managing member of a commercial population health management company, INTERVENT International, LLC. Dr. Barnard has received research funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIH), the National Science Foundation, and the Diabetes Action Research and Education Foundation; and serves without financial compensation as president of the Physicians Committee for Responsible Medicine and Barnard Medical Center, nonprofit organizations providing education, research, and medical care related to nutrition. Dr. Ros has received grants for research through his institution and honoraria as a speaker from and is a nonpaid member of the scientific advisory committee of the
ISSN 0735-1097/$36.00
https://doi.org/10.1016/j.jacc.2018.05.030